Late-breaking presentation at MDA to feature Phase 3 HOPE-3 results supporting Deramiocel in Duchenne muscular dystrophyHOPE-3 clinical study ...
Abbott is facing a warning letter from FDA regarding its Freestyle Libre family of continuous glucose monitoring (CGM) devices for use in diabetes management. The agency said it received responses ...
No one working in the medical device industry is a stranger to FDA warning letters. Every month, FDA compiles a list of infractions from the last 30 days, routinely naming major companies like Abbott, ...
Stocktwits on MSN
CAPR stock rallied nearly 30% so far this week — here’s the February FDA catalyst investors are betting on
The February filing centers on Deramiocel’s Phase 3 Hope-3 data, following the FDA's request for the full clinical study report without requiring new trials. ・The company's Phase 3 results showed ...
(CNN) — The US Food and Drug Administration has refused to accept an application from Moderna to review its first mRNA seasonal flu vaccine, the company said Tuesday, in another setback for the ...
The City of Madison is asking the Social Justice Center to move benches and a food pantry, citing them as contributing to a "public nuisance" Madison Police received 212 calls in the area in 2025, ...
The FDA slammed ExThera with a warning letter for deviating from the regulatory agency’s guidelines by promoting and selling ...
During the first year of the Trump administration, signs of an anti-mRNA slant within the FDA and the Department of Health and Human Services (HHS) became more and more evident. Now, with a refusal-to ...
A batch of untitled letters posted on the FDA’s database in recent days takes aim at what the agency has termed “false or misleading” drug ads from the likes of Novo Nordisk, argenx and Sobi. Among ...
Please provide your email address to receive an email when new articles are posted on . The FDA was not concerned about the drug’s pharmacokinetics. Concerns included packaging, patient use and ...
Marty Makary appeared for Thursday an interview on CNBC to tout efforts under his leadership at the Food and Drug Administration to speed up approvals for treatments of rare diseases. Instead, he ...
The Food and Drug Administration said Novo Nordisk's TV advertisement for its newly launched Wegovy pill for obesity included "false or misleading" claims about the medicine's abilities and benefits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results